Q32 Bio Inc.
NASDAQ:QTTBBiotechnology
Healthcare
$8.48 -1.70%
-$0.22 today
- Market cap
- $253.75M
- Beta
- -0.23
- P/E (TTM)
- 5.4
- EPS (TTM)
- $2.36
52W Low $1.35High $14.85
Volume 0.31M
Average 0.74M
Balance Sheet
Inspect the capital base behind the business.
Assets
$61.78M
FY 2025 · Annual
-33.1% YoYLiabilities
$19.76M
FY 2025 · Annual
-77.2% YoYEquity
$42.01M
FY 2025 · Annual
+640.3% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 108.38M | 43.89M | 25.62M | 77.97M | 48.3M |
| Short-term Investments | 47.49M | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 1.06M | 755K | 555K | 0 |
| Inventory | 0 | 1.75M | 0 | 0 | 0 |
| Other Current Assets | 36.04M | 146K | 83K | 396K | 6.75M |
| Total Current Assets | 191.91M | 46.85M | 28.72M | 81.88M | 55.05M |
| Property, Plant & Equipment (Net) | 17.86M | 9.17M | 8.08M | 7.09M | 6.08M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 1.95M | 25.81M | 5.65M | 2.6M | 647K |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | (20.06M) | 10.26M | 763K | 0 |
| Total Non-current Assets | 19.81M | 14.92M | 18.34M | 10.46M | 6.73M |
| Total Assets | 211.72M | 61.77M | 47.06M | 92.33M | 61.78M |
| Account Payables | 2.37M | 1.44M | 3.47M | 2.99M | 879K |
| Short-term Debt | 246K | 32.4M | 878K | 3.1M | 6.93M |
| Tax Payables | 0 | 570K | 316K | 0 | 0 |
| Deferred Revenue | 3.21M | 14.53M | 0 | 0 | 0 |
| Other Current Liabilities | 11.41M | 2.79M | 3M | 5.68M | 3.54M |
| Total Current Liabilities | 17.23M | 57.87M | 14.11M | 16.47M | 11.35M |
| Long-term Debt | 0 | 5.07M | 43.18M | 9.56M | 3.47M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 1.16M | 11.32M | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 111.45M | 166.45M | 55M | 0 |
| Total Non-current Liabilities | 24.84M | 134.62M | 215.87M | 70.19M | 8.42M |
| Total Liabilities | 42.07M | 192.49M | 229.98M | 86.66M | 19.76M |
| Common Stock | 6K | 6K | 1K | 2K | 2K |
| Retained Earnings | (424.13M) | (429.14M) | (187.08M) | (234.81M) | (204.99M) |
| Accumulated OCI | (7K) | (404K) | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 169.65M | (130.71M) | (182.92M) | 5.68M | 42.01M |
| Total Debt | 23.93M | 44.73M | 50.84M | 18.9M | 15.34M |
| Net Debt | (84.45M) | 838K | 25.22M | (59.06M) | (32.95M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $50.8M |
| Other Current | $6.5M |
| Total Current Assets | $57.2M |
| PP&E (Net) | $5.8M |
| Other Non-current | $647.0K |
| Total Non-current Assets | $6.5M |
| Total Assets | $63.7M |
Analysis
Selected assets total $63.7M for Latest. The largest visible component is Cash & Equivalents at $50.8M, about 79.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 6, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 6, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| SC 13G | SC 13G filing | Oct 28, 2026 |
How much cash does QTTB have?
Q32 Bio Inc. (QTTB) reported $48.30M in cash and equivalents in fiscal 2025.
How much debt does QTTB carry?
Q32 Bio Inc. (QTTB) reported $15.34M of total debt, with net debt of -$32.95M.
Continue the stock analysis
Jump to another research area for this company.